Pages that link to "Item:Q5750260"
From MaRDI portal
The following pages link to The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs (Q5750260):
Displaying 7 items.
- Subject-treatment interactions in crossover trials: performance evaluation of subgrouping methods (Q1779795) (← links)
- Analysis of multiple-dose bioequivalence studies (Q4216072) (← links)
- Individual bioequivalence—a regulatory update (Q4239490) (← links)
- Discussion of individual bioequivalence by M.-L. chen (Q4239493) (← links)
- Individual bioequivalence—a european perspective (Q4239494) (← links)
- Some thoughts on individual bioequivalence (Q4239497) (← links)
- Unit–Treatment Interaction and Its Practical Consequences (Q4670433) (← links)